121 related articles for article (PubMed ID: 11794204)
1. Prophylactic mastectomy in carriers of BRCA mutations.
Narod S
N Engl J Med; 2001 Nov; 345(20):1498; author reply 1499-500. PubMed ID: 11794204
[No Abstract] [Full Text] [Related]
2. Prophylactic mastectomy in carriers of BRCA mutations.
Stoutjesdijk MJ; Barentsz JO
N Engl J Med; 2001 Nov; 345(20):1499; author reply 1499-500. PubMed ID: 11794206
[No Abstract] [Full Text] [Related]
3. Is screening with magnetic resonance imaging in BRCA mutation carriers a safe and effective alternative to prophylactic mastectomy?
Burness ML; Olopade OI
J Clin Oncol; 2011 May; 29(13):1652-4. PubMed ID: 21444875
[No Abstract] [Full Text] [Related]
4. Prophylactic mastectomy in carriers of BRCA mutations.
Riggs T
N Engl J Med; 2001 Nov; 345(20):1499; author reply 1499-500. PubMed ID: 11794205
[No Abstract] [Full Text] [Related]
5. Prophylactic mastectomy in carriers of BRCA mutations.
Offit K; Robson M; Schrag D
N Engl J Med; 2001 Nov; 345(20):1498-9; author reply 1499-500. PubMed ID: 11794203
[No Abstract] [Full Text] [Related]
6. Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group.
Rebbeck TR; Friebel T; Lynch HT; Neuhausen SL; van 't Veer L; Garber JE; Evans GR; Narod SA; Isaacs C; Matloff E; Daly MB; Olopade OI; Weber BL
J Clin Oncol; 2004 Mar; 22(6):1055-62. PubMed ID: 14981104
[TBL] [Abstract][Full Text] [Related]
7. Association between clinical characteristics and risk-reduction interventions in women who underwent BRCA1 and BRCA2 testing: a single-institution study.
Uyei A; Peterson SK; Erlichman J; Broglio K; Yekell S; Schmeler K; Lu K; Meric-Bernstam F; Amos C; Strong L; Arun B
Cancer; 2006 Dec; 107(12):2745-51. PubMed ID: 17109443
[TBL] [Abstract][Full Text] [Related]
8. Use of genetic testing and prophylactic mastectomy and oophorectomy in women with breast or ovarian cancer from families with a BRCA1 or BRCA2 mutation.
Meijers-Heijboer H; Brekelmans CT; Menke-Pluymers M; Seynaeve C; Baalbergen A; Burger C; Crepin E; van den Ouweland AW; van Geel B; Klijn JG
J Clin Oncol; 2003 May; 21(9):1675-81. PubMed ID: 12721241
[TBL] [Abstract][Full Text] [Related]
9. Numerous high-risk epithelial lesions in familial breast cancer.
Hoogerbrugge N; Bult P; Bonenkamp JJ; Ligtenberg MJ; Kiemeney LA; de Hullu JA; Boetes C; Niermeijer MF; Brunner HG
Eur J Cancer; 2006 Oct; 42(15):2492-8. PubMed ID: 16908132
[TBL] [Abstract][Full Text] [Related]
10. Prophylactic mastectomy for BRCA1/2 carriers: progress and more questions.
Hartmann LC; Degnim A; Schaid DJ
J Clin Oncol; 2004 Mar; 22(6):981-3. PubMed ID: 14981099
[No Abstract] [Full Text] [Related]
11. Radiotherapy for breast cancer in BRCA1/BRCA2 carriers: clinical issues and management dilemmas.
Pierce L
Semin Radiat Oncol; 2002 Oct; 12(4):352-61. PubMed ID: 12382193
[TBL] [Abstract][Full Text] [Related]
12. Risk reduction works for BRCA mutation carriers--with heavy costs.
Vanchieri C
J Natl Cancer Inst; 2005 Jul; 97(14):1032-3. PubMed ID: 16030299
[No Abstract] [Full Text] [Related]
13. Preventing breast, ovarian cancer in BRCA carriers: rational of prophylactic surgery and promises of surveillance.
Agnantis NJ; Paraskevaidis E; Roukos D
Ann Surg Oncol; 2004 Dec; 11(12):1030-4. PubMed ID: 15545500
[No Abstract] [Full Text] [Related]
14. Prophylactic surgery in the complex decision-making management of BRCA mutation carriers.
Briasoulis E; Ziogas D; Fatouros M
Ann Surg Oncol; 2008 Jun; 15(6):1788-90; author reply 1791-2. PubMed ID: 18197455
[No Abstract] [Full Text] [Related]
15. Predictors of contralateral prophylactic mastectomy in women with a BRCA1 or BRCA2 mutation: the Hereditary Breast Cancer Clinical Study Group.
Metcalfe KA; Lubinski J; Ghadirian P; Lynch H; Kim-Sing C; Friedman E; Foulkes WD; Domchek S; Ainsworth P; Isaacs C; Tung N; Gronwald J; Cummings S; Wagner T; Manoukian S; Møller P; Weitzel J; Sun P; Narod SA;
J Clin Oncol; 2008 Mar; 26(7):1093-7. PubMed ID: 18195327
[TBL] [Abstract][Full Text] [Related]
16. Perspectives in the clinical management of BRCA mutations carriers.
Savarese A; Cognetti F
J Exp Clin Cancer Res; 2002 Sep; 21(3 Suppl):31-5. PubMed ID: 12585651
[TBL] [Abstract][Full Text] [Related]
17. Unraveling the next chapter: sexual development, body image, and sexual functioning in female BRCA carriers.
Matloff ET; Barnett RE; Bober SL
Cancer J; 2009; 15(1):15-8. PubMed ID: 19197168
[TBL] [Abstract][Full Text] [Related]
18. Reproductive issues for women with BRCA mutations.
Friedman LC; Kramer RM
J Natl Cancer Inst Monogr; 2005; (34):83-6. PubMed ID: 15784831
[TBL] [Abstract][Full Text] [Related]
19. Intra-abdominal carcinomatosis after prophylactic oophorectomy in women of hereditary breast ovarian cancer syndrome kindreds associated with BRCA1 and BRCA2 mutations.
Casey MJ; Synder C; Bewtra C; Narod SA; Watson P; Lynch HT
Gynecol Oncol; 2005 May; 97(2):457-67. PubMed ID: 15863145
[TBL] [Abstract][Full Text] [Related]
20. Management of the BRCA mutation carrier or high-risk patient.
Bordeleau LJ; Lipa JE; Neligan PC
Clin Plast Surg; 2007 Jan; 34(1):15-27; abstract v. PubMed ID: 17307068
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]